Current insights into breast and ovarian cancer risk: a contemporary review.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Minerva surgery

• Publication date

  2025-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.23736/S2724-5691.25.10651-5PMID 40719430PMCID PMC12355728
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interaction between body mass index and family history of cancer on the risk of female breast cancer

  2024cited by this paper
• Historical Redlining, Persistent Mortgage Discrimination, and Race in Breast Cancer Outcomes

  2024cited by this paper
• Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement.

  2024cited by this paper
• The Impact of a Breast Cancer Risk Assessment on the Decision for Gender-Affirming Chest Masculinization Surgery in Transgender and Gender-Diverse Individuals: A Pilot Single-Arm Educational Intervention Trial

  2024cited by this paper
• Deep Learning in Breast Cancer Imaging: State of the Art and Recent Advancements in Early 2024

  2024cited by this paper
• Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

  2024cited by this paper
• Survival rate of ovarian cancer in Asian countries: a systematic review and meta-analysis

  2023cited by this paper
• Breast Cancer Screening and Diagnosis: Recent Advances in Imaging and Current Limitations.

  2023cited by this paper
• Association of Allostatic Load With All-Cause Mortality in Patients With Breast Cancer

  2023cited by this paper
• Assessing Breast and Ovarian Cancer Risk Prior to Gender-Affirming Surgery.

  2023cited by this paper
• Breast Cancer Screening for Women at Higher-than-Average Risk: Updated Recommendations from the ACR.

  2023cited by this paper
• Cancer Screening Rates Among Asian Americans: A Cross-Sectional Secondary Data Analysis Study

  2023cited by this paper
• Breast Cancer and Lifestyle Factors: Umbrella Review.

  2023cited by this paper
• Current Insurance Policy Coverage for Screening Mammography in Transgender and Gender-Diverse Individuals

  2023cited by this paper
• National Estimates of Gender-Affirming Surgery in the US

  2023cited by this paper
• Individualizing Breast Cancer Risk Assessment in Clinical Practice.

  2023cited by this paper
• Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study

  2022cited by this paper
• Breast Cancer Statistics, 2022

  2022cited by this paper
• Mammographic breast density and the risk of breast cancer: A systematic review and meta-analysis

  2022cited by this paper
• Breast Cancer Disparities in Asian Women: The Need for Disaggregated Research

  2022cited by this paper
• Association of Allostatic Load and All Cancer Risk in the SWAN Cohort

  2022cited by this paper
• Analysis of the genomic landscapes of Barbadian and Nigerian women with triple negative breast cancer

  2022cited by this paper
• Allostatic Load and Mortality: A Systematic Review and Meta-Analysis.

  2022cited by this paper
• Management of breast complaints and high-risk lesions.

  2022cited by this paper
• Trends in Breast Cancer Incidence, by Race, Ethnicity, and Age Among Women Aged ≥20 Years — United States, 1999–2018

  2022cited by this paper
• Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: a prospective cohort study.

  2021cited by this paper
• Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.

  2021cited by this paper
• Disease characteristics and mortality among Asian women with breast cancer

  2021cited by this paper
• Non-BRCA1/BRCA2 high-risk familial breast cancers are not associated with a high prevalence of BRCAness

  2021cited by this paper
• Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review

  2021cited by this paper
• Breast Cancer Risk and Screening in Transgender Persons: A Call for Inclusive Care

  2021cited by this paper
• Hair product use and breast cancer incidence in the Black Women's Health Study.

  2021cited by this paper
• Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

  2021cited by this paper
• Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer.

  2021cited by this paper
• Risk-Reducing Mastectomy.

  2021cited by this paper
• Allostatic score and its associations with demographics, healthy behaviors, tumor characteristics, and mitochondrial DNA among breast cancer patients

  2021cited by this paper
• Epidemiology of Triple-Negative Breast Cancer: A Review.

  2021cited by this paper
• A Population-Based Study of Genes Previously Implicated in Breast Cancer.

  2021cited by this paper
• Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.

  2020cited by this paper
• A critical review of talc and ovarian cancer

  2020cited by this paper
• Novel Approaches to Screening for Breast Cancer.

  2020cited by this paper
• Annual report to the nation on the status of cancer, part II: Progress toward Healthy People 2020 objectives for 4 common cancers

  2020cited by this paper
• Breast cancer statistics, 2019

  2019cited by this paper
• Higher Breast Cancer Risk Among Immigrant Asian American Women Than Among US-Born Asian American Women

  2019cited by this paper
• Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands

  2019cited by this paper
• Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

  2019cited by this paper
• Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.

  2019cited by this paper
• Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence

  2019cited by this paper
• The Tyrer–Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS

  2019cited by this paper
• Performance of breast cancer risk assessment models in a large mammography cohort.

  2019cited by this paper
• Overview of radiomics in breast cancer diagnosis and prognostication

  2019cited by this paper
• Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines

  2019cited by this paper
• Factors predicting reclassification of variants of unknown significance.

  2018cited by this paper
• Ovarian cancer screening-ultrasound; impact on ovarian cancer mortality.

  2018cited by this paper
• Environmental Determinants of Breast Cancer.

  2018cited by this paper
• Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density

  2018cited by this paper
• Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis

  2018cited by this paper
• Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women.

  2017cited by this paper
• Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.

  2017cited by this paper
• Breast Cancer Risk Assessment Models and High-Risk Screening.

  2017cited by this paper
• Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians

  2017cited by this paper
• Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

  2017cited by this paper
• Breast cancer subtype distribution is different in normal weight, overweight, and obese women

  2017cited by this paper
• Ovarian cancer: epidemiology and risk factors.

  2017cited by this paper
• Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study

  2017cited by this paper
• Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.

  2016cited by this paper
• Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.

  2016cited by this paper
• Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force

  2016cited by this paper
• Inherited Mutations in Women With Ovarian Carcinoma.

  2016cited by this paper
• A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change

  2015cited by this paper
• Genetics of breast cancer: a topic in evolution.

  2015cited by this paper
• Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study

  2015cited by this paper
• Asian American women in California: a pooled analysis of predictors for breast and cervical cancer screening.

  2015cited by this paper
• Breast cancer after chest radiation therapy for childhood cancer.

  2014cited by this paper
• Breast density and breast cancer risk: a practical review.

  2014cited by this paper
• Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose‐response meta‐analysis

  2013cited by this paper
• Prophylactic Salpingectomy and Delayed Oophorectomy as an Alternative for BRCA Mutation Carriers

  2013cited by this paper
• Oral Contraceptive Pills as Primary Prevention for Ovarian Cancer: A Systematic Review and Meta-analysis

  2013cited by this paper
• Outcome for Patients with Triple-Negative Breast Cancer Is Not Dependent on Race/Ethnicity

  2012cited by this paper
• Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia.

  2010cited by this paper
• Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

  2010cited by this paper
• Errors in delivery of cancer genetics services: implications for practice.

  2010cited by this paper
• Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States.

  2009cited by this paper
• Understanding and treating triple-negative breast cancer.

  2008cited by this paper
• Society of Surgical Oncology: Position Statement on Prophylactic Mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007

  2007cited by this paper
• Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2.

  2007cited by this paper
• Barriers for breast cancer screening among Asian women: a mini literature review.

  2006cited by this paper
• Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.

  2005cited by this paper
• Mammographic Breast Density and the Gail Model for Breast Cancer Risk Prediction in a Screening Population

  2005cited by this paper
• Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

  2004cited by this paper
• The BOADICEA model of genetic susceptibility to breast and ovarian cancer

  2004cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.

  2001cited by this paper
• Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.

  1998cited by this paper
• Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

  1997cited by this paper
• Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction

  1994cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Stress and the individual. Mechanisms leading to disease.

  1993cited by this paper
• Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

  1989cited by this paper

• Gene driven analytical learning model for accurate breast cancer diagnosis

  2026cites this paper